Pluri Inc. Reimbursement Revenue (Deprecated 2018-01-31)
Pluri Inc. (PLUR) reported Reimbursement Revenue (Deprecated 2018-01-31) of $10.00 million for the 9-month period ending 2016-03-31, per its 10-Q filed 2016-05-09.
Discontinued › Income Statement › Other Income
us-gaap:ReimbursementRevenue · last filed 2016-05-09
- Pluri Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $0.00.
- Pluri Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $0.00.
- Pluri Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $10.00M, a 0.00% change year-over-year.
- Pluri Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $0.00.
- Pluri Inc. reimbursement revenue (deprecated 2018-01-31) for fiscal 2015 was $10.00M, a 0.00% change from fiscal 2014.
- Pluri Inc. reimbursement revenue (deprecated 2018-01-31) for fiscal 2014 was $10.00M.
| Period end | Reimbursement Revenue (Deprecated 2018-01-31) 3 month | Reimbursement Revenue (Deprecated 2018-01-31) 6 month | Reimbursement Revenue (Deprecated 2018-01-31) 9 month | Reimbursement Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2016-05-09 | $10.00M 10-Q · filed 2016-05-09 | $10.00M derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | $10.00M 10-Q · filed 2016-02-08 | $10.00M derived: sum of 3 quarters · filed 2016-02-08 | $10.00M derived: sum of 4 quarters · filed 2016-02-08 |
| 2015-09-30 | $10.00M 10-Q · filed 2015-11-05 | $10.00M derived: sum of 2 quarters · filed 2015-11-05 | $10.00M derived: sum of 3 quarters · filed 2015-11-05 | $10.00M derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $0.00 derived: sum of 2 quarters · filed 2015-09-09 | $0.00 derived: sum of 3 quarters · filed 2015-09-09 | $10.00M 10-K · filed 2015-09-09 |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $0.00 derived: sum of 2 quarters · filed 2015-05-06 | $10.00M 10-Q · filed 2015-05-06 | $10.00M derived: sum of 4 quarters · filed 2015-05-06 |
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $10.00M 10-Q · filed 2015-02-05 | $10.00M derived: sum of 3 quarters · filed 2015-02-05 | |
| 2014-09-30 | $10.00M 10-Q · filed 2014-11-06 | $10.00M derived: sum of 2 quarters · filed 2014-11-06 | ||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | $10.00M 10-K · filed 2014-09-11 | ||
| 2014-03-31 | $10.00M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |